Jake P. Mann

2.4k total citations · 1 hit paper
55 papers, 1.3k citations indexed

About

Jake P. Mann is a scholar working on Epidemiology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Jake P. Mann has authored 55 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Epidemiology, 17 papers in Surgery and 17 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Jake P. Mann's work include Liver Disease Diagnosis and Treatment (29 papers), Diet, Metabolism, and Disease (16 papers) and Liver Disease and Transplantation (8 papers). Jake P. Mann is often cited by papers focused on Liver Disease Diagnosis and Treatment (29 papers), Diet, Metabolism, and Disease (16 papers) and Liver Disease and Transplantation (8 papers). Jake P. Mann collaborates with scholars based in United Kingdom, Italy and Germany. Jake P. Mann's co-authors include Valério Nobili, David B. Savage, Jiali Gao, Matthew J. Armstrong, Luca Valenti, Jeremy D. Hayden, Christopher D. Byrne, Eleonora Scorletti, Julian H. Barth and Adam D Jakes and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Jake P. Mann

55 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement

2021 163 citations Mohammed Eslam, Naim Alkhouri et al. The Lancet. Gastroenterology & hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jake P. Mann United Kingdom	18	787	376	341	255	243	55	1.3k
Rebecca Marzocchi Italy	16	798 1.0×	411 1.1×	249 0.7×	351 1.4×	306 1.3×	28	1.3k
Chrysoula Boutari Greece	17	496 0.6×	414 1.1×	198 0.6×	123 0.5×	211 0.9×	43	1.1k
Simona Moscatiello Italy	19	1.1k 1.5×	857 2.3×	214 0.6×	289 1.1×	302 1.2×	29	1.9k
Lucia Brodosi Italy	15	441 0.6×	253 0.7×	181 0.5×	218 0.9×	267 1.1×	39	956
Heather Hofflich United States	11	592 0.8×	368 1.0×	141 0.4×	223 0.9×	108 0.4×	18	1.0k
Mikael Knutsson Sweden	17	425 0.5×	175 0.5×	270 0.8×	88 0.3×	134 0.6×	40	1.3k
Daniel Ferraz de Campos Mazo Brazil	18	603 0.8×	234 0.6×	115 0.3×	373 1.5×	122 0.5×	59	911
Jorge Rojas Flores Chile	18	489 0.6×	239 0.6×	771 2.3×	109 0.4×	425 1.7×	42	1.4k
Y Matsuzawa Japan	17	317 0.4×	207 0.6×	208 0.6×	62 0.2×	304 1.3×	37	1.1k
René Baudrand Chile	25	327 0.4×	1.2k 3.3×	715 2.1×	70 0.3×	215 0.9×	68	1.9k

Countries citing papers authored by Jake P. Mann

Since Specialization

Citations

This map shows the geographic impact of Jake P. Mann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jake P. Mann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jake P. Mann more than expected).

Fields of papers citing papers by Jake P. Mann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jake P. Mann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jake P. Mann. The network helps show where Jake P. Mann may publish in the future.

Co-authorship network of co-authors of Jake P. Mann

This figure shows the co-authorship network connecting the top 25 collaborators of Jake P. Mann. A scholar is included among the top collaborators of Jake P. Mann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jake P. Mann. Jake P. Mann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tan, Jennifer, Pojsakorn Danpanichkul, Jake P. Mann, et al.. (2025). Meta‐Analysis: Effects of Steatotic Liver Disease‐Associated Genetic Risk Alleles on Longitudinal Outcomes. Alimentary Pharmacology & Therapeutics. 62(3). 244–276. 2 indexed citations

Wan, Leo Q., et al.. (2023). A Case Report of Steroid-Induced Angioedema and Urticaria. Cureus. 15(10). e46515–e46515. 1 indexed citations

Mann, Jake P., Benjamin Jenkins, Samuel Furse, et al.. (2022). Comparison of the Lipidomic Signature of Fatty Liver in Children and Adults. Journal of Pediatric Gastroenterology and Nutrition. 74(6). 734–741. 6 indexed citations

Mann, Jake P. & Matthew Hoare. (2022). A minority of somatically mutated genes in pre‐existing fatty liver disease have prognostic importance in the development of NAFLD. Liver International. 42(8). 1823–1835. 7 indexed citations

Mann, Jake P., Dominic Lenz, Zania Stamataki, & Déirdre Kelly. (2022). Common mechanisms in pediatric acute liver failure. Trends in Molecular Medicine. 29(3). 228–240. 6 indexed citations

Mann, Jake P., Dennis L. Caruana, Eric Gottesman, et al.. (2022). Attenuation of Human Growth Hormone-Induced Rash With Graded Dose Challenge. Cureus. 14(8). e27920–e27920. 2 indexed citations

Eslam, Mohammed, Naim Alkhouri, Pietro Vajro, et al.. (2021). Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement. The Lancet. Gastroenterology & hepatology. 6(10). 864–873. 163 indexed citations breakdown →

Hensel, Kai O., Eirini Kyrana, Nedim Hadžić, et al.. (2021). Sclerosing Cholangitis in Pediatric Inflammatory Bowel Disease: Early Diagnosis and Management Affect Clinical Outcome. The Journal of Pediatrics. 238. 50–56.e3. 8 indexed citations

Hunter, Harriet, Yu Ri Im, Jiawen Dong, et al.. (2020). Weight loss, insulin resistance, and study design confound results in a meta-analysis of animal models of fatty liver. eLife. 9. 9 indexed citations

10.

Mann, Jake P., Paul Carter, Matthew J. Armstrong, et al.. (2020). Hospital admission with non-alcoholic fatty liver disease is associated with increased all-cause mortality independent of cardiovascular risk factors. PLoS ONE. 15(10). e0241357–e0241357. 8 indexed citations

11.

Wilkinson, James, et al.. (2019). Clinical outcomes in pediatric intestinal failure: a meta-analysis and meta-regression. American Journal of Clinical Nutrition. 110(2). 430–436. 42 indexed citations

12.

Mann, Jake P., Anita Vreugdenhil, Piotr Socha, et al.. (2018). European paediatric non-alcoholic fatty liver disease registry (EU-PNAFLD): Design and rationale. Contemporary Clinical Trials. 75. 67–71. 11 indexed citations

13.

Mann, Jake P. & Quentin M. Anstee. (2017). PNPLA3 and obesity: a synergistic relationship in NAFLD. Nature Reviews Gastroenterology & Hepatology. 14(9). 506–507. 27 indexed citations

14.

Than, Nwe Ni, et al.. (2016). Difference in clinical presentation, immunology profile and treatment response of type 1 autoimmune hepatitis between United Kingdom and Singapore patients. Hepatology International. 10(4). 673–679. 6 indexed citations

15.

Mann, Jake P., Robert K. Semple, & Matthew J. Armstrong. (2016). How Useful Are Monogenic Rodent Models for the Study of Human Non-Alcoholic Fatty Liver Disease?. Frontiers in Endocrinology. 7. 145–145. 20 indexed citations

16.

Mann, Jake P., et al.. (2015). Paediatric non-alcoholic fatty liver disease: a practical overview for non-specialists. Archives of Disease in Childhood. 100(7). 673–677. 15 indexed citations

17.

Than, Nwe Ni, Christiane Wiegard, Christina Weiler‐Normann, et al.. (2015). Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on Tacrolimus therapy. Scandinavian Journal of Gastroenterology. 51(3). 329–336. 39 indexed citations

18.

Ward, Peter J., et al.. (2015). Self-reported extracurricular activity, academic success, and quality of life in UK medical students. International Journal of Medical Education. 6. 111–117. 43 indexed citations

19.

Natalwala, Ammar, et al.. (2014). Co-morbidities and mortality associated with intracranial bleeds and ischaemic stroke. International Journal of Neuroscience. 125(4). 256–263. 4 indexed citations

20.

Armstrong, Matthew J., Jonathan Hazlehurst, Richard Parker, et al.. (2013). Severe asymptomatic non-alcoholic fatty liver disease in routine diabetes care; a multi-disciplinary team approach to diagnosis and management. QJM. 107(1). 33–41. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact